This ongoing rollout of product examples will make AGP's task of finding institutional investors magnitudes easier.

And the ceiling for nFusz pricing appears greater by the day as adoption becomes a no brainer in specific but ever expanding industries.

I own two stocks with seemingly great upside. My daydreams are becoming more pleasant.